Literature DB >> 2803935

Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.

M Tiainen1, L Tammilehto, J Rautonen, T Tuomi, K Mattson, S Knuutila.   

Abstract

Cytogenetic findings of our 30 previously reported and eight new patients with malignant pleural mesothelioma were summarised and correlated with asbestos fibre burden in lung tissue and survival. Successful cytogenetic analyses were performed on cells obtained from the tumours and/or pleural effusions of 34 of the 38 patients. Clonal chromosomal abnormalities were detected in 25 patients, 19 of them studied before treatment. Nine patients, seven of them studied before treatment, had normal karyotypes and/or non-clonal chromosomal abnormalities. Most of the karyotypic findings in the patients with clonal abnormalities were complex and heterogeneous, and no chromosome aberration specific to mesothelioma could be demonstrated. The following numerical abnormalities in decreasing order of frequency were preferentially present in karyotypic changes: -22, +7, -1, -3, -9, +11 and -14 (-/+ denoting partial or total loss or gain). Translocations and deletions involving a breakpoint at 1p11-p22 were the most frequent structural aberrations. Statistically significant correlations were found between high content of asbestos fibres in lung tissue and partial or total losses of chromosomes 1 and 4, and a breakpoint at 1p11-p22 (P = 0.0001, P = 0.003, P = 0.009, respectively). The number of copies of chromosome 7 short arms was inversely correlated with survival (P = 0.02). In this study no diagnostic cytogenetic markers of mesothelioma were found, instead the copy number of chromosome 7 short arms turned out to be a possible prognostic factor in malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803935      PMCID: PMC2247120          DOI: 10.1038/bjc.1989.326

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Asbestos-associated chromosomal changes in human mesothelial cells.

Authors:  J F Lechner; T Tokiwa; M LaVeck; W F Benedict; S Banks-Schlegel; H Yeager; A Banerjee; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

Review 2.  Current concepts: malignant mesothelioma.

Authors:  K H Antman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

3.  Cytological and cytogenetical studies on human meningioma.

Authors:  K D Zang
Journal:  Cancer Genet Cytogenet       Date:  1982-07

4.  Monosomy 14, monosomy 22 and 13q--three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques.

Authors:  J Mark
Journal:  Acta Cytol       Date:  1978 Sep-Oct       Impact factor: 2.319

5.  [Identification by means of heat denaturation of chromosome aberrations in 6 human metastatic tumors].

Authors:  N Ayraud
Journal:  Biomedicine       Date:  1975-12-20

6.  Chromosomes and causation of human cancer and leukemia. XLIV. A method for chromosome analysis of solid tumors.

Authors:  N Wake; H K Slocum; Y M Rustum; S Matsui; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1981-01

7.  A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC).

Authors:  J Whang-Peng; P A Bunn; C S Kao-Shan; E C Lee; D N Carney; A Gazdar; J D Minna
Journal:  Cancer Genet Cytogenet       Date:  1982-06

8.  Karyotypic evolution in human malignant melanoma.

Authors:  G B Balaban; M Herlyn; W H Clark; P C Nowell
Journal:  Cancer Genet Cytogenet       Date:  1986-01-01

9.  Break points in chromosome #1 abnormalities of 218 human neoplasms.

Authors:  V Brito-Babapulle; N B Atkin
Journal:  Cancer Genet Cytogenet       Date:  1981-11

10.  Ultrastructural diagnosis of epithelial malignant mesothelioma.

Authors:  T R Burns; S D Greenberg; M L Mace; E H Johnson
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

View more
  14 in total

1.  Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.

Authors:  Didier Jean; Emilie Thomas; Elodie Manié; Annie Renier; Aurélien de Reynies; Céline Lecomte; Pascal Andujar; Jocelyne Fleury-Feith; Françoise Galateau-Sallé; Marco Giovannini; Jessica Zucman-Rossi; Marc-Henri Stern; Marie-Claude Jaurand
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.

Authors:  Satu Mäki-Nevala; Virinder Kaur Sarhadi; Aija Knuuttila; Ilari Scheinin; Pekka Ellonen; Sonja Lagström; Mikko Rönty; Eeva Kettunen; Kirsti Husgafvel-Pursiainen; Henrik Wolff; Sakari Knuutila
Journal:  Lung       Date:  2016-02       Impact factor: 2.584

3.  Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.

Authors:  Aaron S Mansfield; Tobias Peikert; James B Smadbeck; Julia B M Udell; Enrique Garcia-Rivera; Laura Elsbernd; Courtney L Erskine; Virginia P Van Keulen; Farhad Kosari; Stephen J Murphy; Hongzheng Ren; Vishnu V Serla; Janet L Schaefer Klein; Giannoula Karagouga; Faye R Harris; Carlos Sosa; Sarah H Johnson; Wendy Nevala; Svetomir N Markovic; Aaron O Bungum; Eric S Edell; Haidong Dong; John C Cheville; Marie Christine Aubry; Jin Jen; George Vasmatzis
Journal:  J Thorac Oncol       Date:  2018-10-10       Impact factor: 15.609

4.  Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney.

Authors:  S Knuutila; M L Larramendy; P Elfving; W el-Rifai; A Miettinen; F Mitelman
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

Review 5.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.

Authors:  C Sreekantaiah; M Ladanyi; E Rodriguez; R S Chaganti
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

6.  Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach.

Authors:  C J Langer; N Rosenblum; M Hogan; S Nash; P Bagchi; F P LaCreta; R Catalano; R L Comis; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.

Authors:  Jingquan Han; Shouqiang Cao; Kai Zhang; Guibin Zhao; Yanzhong Xin; Qing Dong; Yubo Yan; Jian Cui
Journal:  J Cardiothorac Surg       Date:  2012-11-13       Impact factor: 1.637

8.  Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.

Authors:  Penny Nymark; Pamela M Lindholm; Mikko V Korpela; Leo Lahti; Salla Ruosaari; Samuel Kaski; Jaakko Hollmén; Sisko Anttila; Vuokko L Kinnula; Sakari Knuutila
Journal:  BMC Genomics       Date:  2007-03-01       Impact factor: 3.969

9.  Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.

Authors:  A M Björkqvist; L Tammilehto; S Nordling; M Nurminen; S Anttila; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

10.  Phenotypes and karyotypes of human malignant mesothelioma cell lines.

Authors:  Vandana Relan; Leanne Morrison; Kylie Parsonson; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Kwun M Fong; Rayleen V Bowman
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.